Literature DB >> 18795803

The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor.

Farah El-Turk1, Michele Cascella, Hajer Ouertatani-Sakouhi, Raghavendran Lakshmi Narayanan, Lin Leng, Richard Bucala, Markus Zweckstetter, Ursula Rothlisberger, Hilal A Lashuel.   

Abstract

Macrophage migration inhibitory factor (n class="Gene">MIF) is a multifunctional protein and a major mediator of innate immunity. Although X-ray crystallography revealed that MIF exists as a homotrimer, its oligomerization state in vivo and the factors governing its oligomerization and stability remain poorly understood. The C-terminal region of MIF is highly conserved and participates in several intramolecular interactions that suggest a role in modulating the stability and biochemical activity of MIF. To determine the importance of these interactions, point mutations (A48P, L46A), insertions (P107) at the monomer-monomer interfaces, and C-terminal deletion (Delta 110-114NSTFA and Delta 105-114NVGWNNSTFA) variants were designed and their structural properties, thermodynamic stability, oligomerization state, catalytic activity and receptor binding were characterized using a battery of biophysical methods. The C-terminal deletion mutants DeltaC5 huMIF 1-109 and DeltaC10 huMIF 1-104 were enzymatically inactive and thermodynamically less stable than wild type MIF. Analytical ultracentrifugation studies demonstrate that both C-terminal mutants sediment as trimers and exhibit similar binding to CD74 as the wild type protein. Disrupting the conformation of the C-terminal region 105-114 and increasing its conformational flexibility through the insertion of a proline residue at position 107 was sufficient to reproduce the structural, biochemical and thermodynamic properties of the deletion mutants. P107 MIF forms an enzymatically inactive trimer and exhibits reduced thermodynamic stability relative to the wild type protein. To provide a rationale for the changes induced by these mutations at the molecular level, we also performed molecular dynamics simulations on these mutants in comparison to the wild type MIF. Together, our studies demonstrate that intersubunit interactions involving the C-terminal region 105-114, including a salt-bridge interaction between Arg73 of one monomer and the carboxy terminus of a neighboring monomer, play critical roles in modulating tertiary structure stabilization, enzymatic activity, and thermodynamic stability of MIF, but not its oligomerization state and receptor binding properties. Our results suggest that targeting the C-terminal region could provide new strategies for allosteric modulation of MIF enzymatic activity and the development of novel inhibitors of MIF tautomerase activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18795803      PMCID: PMC3642871          DOI: 10.1021/bi800603x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  47 in total

1.  Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes.

Authors:  N Yabunaka; J Nishihira; Y Mizue; M Tsuji; M Kumagai; Y Ohtsuka; M Imamura; M Asaka
Journal:  Diabetes Care       Date:  2000-02       Impact factor: 19.112

2.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

3.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

4.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

Authors:  R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

5.  Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.

Authors:  M Orita; S Yamamoto; N Katayama; M Aoki; K Takayama; Y Yamagiwa; N Seki; H Suzuki; H Kurihara; H Sakashita; M Takeuchi; S Fujita; T Yamada; A Tanaka
Journal:  J Med Chem       Date:  2001-02-15       Impact factor: 7.446

6.  The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.

Authors:  G Fingerle-Rowson; O Petrenko; C N Metz; T G Forsthuber; R Mitchell; R Huss; U Moll; W Müller; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

7.  Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.

Authors:  Xiangdong Xu; Bo Wang; Caisheng Ye; Chen Yao; Ying Lin; Xueling Huang; Yunjian Zhang; Shenming Wang
Journal:  Cancer Lett       Date:  2008-01-02       Impact factor: 8.679

8.  Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.

Authors:  M E Pyle; M Korbonits; M Gueorguiev; S Jordan; B Kola; D G Morris; A Meinhardt; M P Powell; F X Claret; Q Zhang; C Metz; R Bucala; A B Grossman
Journal:  J Endocrinol       Date:  2003-01       Impact factor: 4.286

9.  Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis.

Authors:  Thierry Calandra; Céline Froidevaux; Christian Martin; Thierry Roger
Journal:  J Infect Dis       Date:  2003-06-15       Impact factor: 5.226

10.  MIF signal transduction initiated by binding to CD74.

Authors:  Lin Leng; Christine N Metz; Yan Fang; Jing Xu; Seamas Donnelly; John Baugh; Thomas Delohery; Yibang Chen; Robert A Mitchell; Richard Bucala
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  19 in total

1.  The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).

Authors:  Melanie Merk; Swen Zierow; Lin Leng; Rituparna Das; Xin Du; Wibke Schulte; Juan Fan; Hongqi Lue; Yibang Chen; Huabao Xiong; Frederic Chagnon; Jürgen Bernhagen; Elias Lolis; Gil Mor; Olivier Lesur; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-04       Impact factor: 11.205

Review 2.  Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer.

Authors:  Camila Cristina Guimarães Nobre; Josélio Maria Galvão de Araújo; Thales Allyrio Araújo de Medeiros Fernandes; Ricardo Ney Oliveira Cobucci; Daniel Carlos Ferreira Lanza; Vânia Sousa Andrade; José Veríssimo Fernandes
Journal:  Pathol Oncol Res       Date:  2016-10-23       Impact factor: 3.201

3.  Comparative analysis of macrophage migration inhibitory factors (MIFs) from the parasitic nematode Onchocerca volvulus and the free-living nematode Caenorhabditis elegans.

Authors:  Irene Ajonina-Ekoti; Marc Andre Kurosinski; Abuelhassan Elshazly Younis; Dieudonne Ndjonka; Manchang Kingsley Tanyi; Mbunkah Achukwi; Albert Eisenbarth; Caroline Ajonina; Kai Lüersen; Minka Breloer; Norbert W Brattig; Eva Liebau
Journal:  Parasitol Res       Date:  2013-07-03       Impact factor: 2.289

4.  Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.

Authors:  Roberto Meza-Romero; Gil Benedek; Lin Leng; Richard Bucala; Arthur A Vandenbark
Journal:  Metab Brain Dis       Date:  2016-02-06       Impact factor: 3.584

5.  Ostertagia ostertagi macrophage migration inhibitory factor is present in all developmental stages and may cross-regulate host functions through interaction with the host receptor.

Authors:  Guanggang Qu; Raymond Fetterer; Lin Leng; Xin Du; Dante Zarlenga; Zhiqiang Shen; Wenyu Han; Richard Bucala; Wenbin Tuo
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

6.  A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.

Authors:  Günter Fingerle-Rowson; Dayananda Rao Kaleswarapu; Corinna Schlander; Nazanin Kabgani; Tania Brocks; Nina Reinart; Raymonde Busch; Anke Schütz; Hongqi Lue; Xin Du; Aihua Liu; Huabao Xiong; Yibang Chen; Alice Nemajerova; Michael Hallek; Jürgen Bernhagen; Lin Leng; Richard Bucala
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

7.  Crystal structure of a macrophage migration inhibitory factor from Giardia lamblia.

Authors:  Garry W Buchko; Jan Abendroth; Howard Robinson; Yanfeng Zhang; Stephen N Hewitt; Thomas E Edwards; Wesley C Van Voorhis; Peter J Myler
Journal:  J Struct Funct Genomics       Date:  2013-05-25

8.  Homotrimeric macrophage migration inhibitory factor (MIF) drives inflammatory responses in the corneal epithelium by promoting caveolin-rich platform assembly in response to infection.

Authors:  Thomas Reidy; Alexander Rittenberg; Markryan Dwyer; Samantha D'Ortona; Gerald Pier; Mihaela Gadjeva
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

9.  MIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrations.

Authors:  Chengpeng Fan; Deepa Rajasekaran; Mansoor Ali Syed; Lin Leng; J Patrick Loria; Vineet Bhandari; Richard Bucala; Elias J Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

10.  The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei.

Authors:  Sarah E Dobson; Kevin D Augustijn; James A Brannigan; Claudia Schnick; Chris J Janse; Eleanor J Dodson; Andrew P Waters; Anthony J Wilkinson
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.